Alimera Sciences, Inc. (ALIM)
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
$301.29M
Mr. Richard S. Eiswirth Jr.
145.00
Alpharetta, GA
Apr 22, 2010
5.28
$1.05
0.55
2.79
-14.74%
-20.50
-1.60
7.77
3.02
2.62
-9.77%
-33.70%
Similar stocks (6)
Organogenesis Holdings Inc.
ORGO
Lifecore Biomedical, Inc.
LFCR
Journey Medical Corporation
DERM
Cyclo Therapeutics, Inc.
CYTH
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
Petros Pharmaceuticals, Inc.
PTPI
ETF Exposure (16)
iShares Micro-Cap ETF
IWC
0.03229%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00841%
iShares Russell 2000 ETF
IWM
0.00462%
ProShares Ultra Russell2000
UWM
0.0017593629036231637%
iShares Russell 2000 Value ETF
IWN
0.00105%
ProShares UltraPro Russell2000
URTY
8.665925637956373e-4%
ProShares Hedge Replication ETF
HDG
7.359437543371063e-4%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (6)
Organogenesis Holdings Inc.
ORGO
Lifecore Biomedical, Inc.
LFCR
Journey Medical Corporation
DERM
Cyclo Therapeutics, Inc.
CYTH
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
Petros Pharmaceuticals, Inc.
PTPI
ETF Exposure (16)
iShares Micro-Cap ETF
IWC
0.03229%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00841%
iShares Russell 2000 ETF
IWM
0.00462%
ProShares Ultra Russell2000
UWM
0.0017593629036231637%
iShares Russell 2000 Value ETF
IWN
0.00105%
ProShares UltraPro Russell2000
URTY
8.665925637956373e-4%
ProShares Hedge Replication ETF
HDG
7.359437543371063e-4%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%